Jasper Therapeutics names Greg Keenan as chief medical officer in initial beneficial ownership filing
JSPR•Chief medical officer disclosure
Jasper Therapeutics Chief Medical Officer Greg Keenan disclosed stock options for 103,204 shares of voting common stock at $0.01.
